Filing Details
- Accession Number:
- 0001415889-24-008841
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-21 16:30:14
- Reporting Period:
- 2024-03-19
- Accepted Time:
- 2024-03-21 16:30:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1082554 | United Therapeutics Corp | UTHR | Pharmaceutical Preparations (2834) | 521984749 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1106578 | A Martine Rothblatt | C/O United Therapeutics Corporation 1000 Spring Street Silver Spring MD 20910 | Chairperson & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-03-19 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-19 | 1,227 | $233.25 | 13,903 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-19 | 975 | $233.98 | 12,928 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-19 | 2,409 | $235.08 | 10,519 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-19 | 2,958 | $236.28 | 7,561 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-19 | 2,953 | $237.08 | 4,608 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-19 | 2,825 | $238.48 | 1,783 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-19 | 1,653 | $239.30 | 130 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2024-03-20 | 15,000 | $129.49 | 15,130 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-03-20 | 2,290 | $234.33 | 12,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-20 | 3,642 | $235.19 | 9,198 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-20 | 6,055 | $236.37 | 3,143 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-20 | 2,863 | $237.21 | 280 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2024-03-20 | 150 | $238.28 | 130 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Options | Disposition | 2024-03-19 | 15,000 | $0.00 | 15,000 | $129.49 |
| Common Stock | Stock Options | Disposition | 2024-03-20 | 15,000 | $0.00 | 15,000 | $129.49 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 551,654 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
| 536,654 | 2014-12-31 | 2024-12-31 | No | 4 | M | Direct |
Footnotes
- This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on August 4, 2023. This plan will continue until the earlier of: (a) exhaustion of a tranche of 723,869 stock options that expire December 31, 2024; or (b) August 31, 2024.
- This transaction was executed in multiple trades at prices ranging from $232.57 to $233.565. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $233.60 to $234.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $234.635 to $235.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.66 to $236.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $236.66 to $237.59. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $238.13 to $239.02. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $239.17 to $239.43. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $233.855 to $234.845. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $234.88 to $235.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $235.885 to $236.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $236.875 to $237.77. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
